The effects of CYP24A1 on clinicopathological features and the prognosis of pancreatic ductal adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a type of exocrine pancreatic cancer that presents itself in the form of a highly malignant tumor. However, in the past few decades, with breakthroughs in the diagnosis and treatment of malignant tumors, there have yet to be satisfactory results...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Wei, Wang, Teng-Fei, Yi, Wen, Tong, Wei-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798510/
https://www.ncbi.nlm.nih.gov/pubmed/35117813
http://dx.doi.org/10.21037/tcr.2020.02.78

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798510/
https://www.ncbi.nlm.nih.gov/pubmed/35117813
http://dx.doi.org/10.21037/tcr.2020.02.78

Ejemplares similares